You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昭衍新藥(06127.HK)上半年淨利升70.39%至1.54億元 繼續擴大人員隊伍
格隆匯 08-30 22:50

格隆匯8月30日丨昭衍新藥(06127.HK)發佈2021年半年度報吿,實現營業收入人民幣5.35億元(單位下同),同比增長34.53%;歸屬於上市公司股東的淨利潤1.54億元,同比增長70.39%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.29億元,同比增長64.46%;基本每股收益0.60元。

隊伍方面,為了適應公司業務及訂單的不斷增長,公司繼續擴大人員隊伍,截至2021年6月30日,公司已擁有近1600人的專業服務團隊,臨牀前研究服務團隊人員的數量和技術能力進一步提高,臨牀試驗服務團隊也進一步充實。公司也在繼續優化組織架構,細化崗位職責,優化管理流程,並結合新架構、新技術的引進,不斷完善人才體系搭建,持續提高員工的勞動積極性;同時,公司進一步優化薪酬體系,為員工提供了較為有競爭力的薪酬方案,大大提升了員工的主人翁意識;公司繼續堅持員工隊伍培養教育,搭建了系統的內部技術培訓和考核,開展校企合作,為員工創新學習能力和專業技術能力的提升提供更多的機會和保障。

產能建設方面,由於公司承接臨牀前評價項目保持高速增長,現有實驗設施已不能完全滿足市場需求,為此,昭衍(蘇州)於2021年啟動約7,500平米的動物房裝修工程,包含普通級大動物房和SPF級動物房,預計本年底前可投入使用。同時考慮後續業務發展,昭衍(蘇州)也開始着手在現有土地上進行II期工程的擴充建設工作,共計劃增加建築面積約25,000平米,計劃2021年下半年開始動工,新建設施仍以動物飼養管理為主,並配套新的動力中心以及IT機房等輔助設施,新設施的建設將進一步提升服務通量,為未來的業務執行和業績增長提供保障。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account